Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
- PMID: 10326538
- DOI: 10.1016/S0140-6736(98)07333-4
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
Abstract
Background: Treatment and prevention of HIV-1-related central-nervous-system disease may be dependent on penetration of antiretroviral drugs into the central nervous system. Few data are available about cerebrospinal-fluid penetration and concomitant changes of HIV-1-RNA concentrations during treatment with antiretroviral agents. We investigated these effects in HIV-1-infected people.
Methods: 28 antiretroviral-naive individuals with CD4 cell counts of 200/microL or more and plasma HIV-1-RNA concentrations of 10,000 or more copies/mL who were free of neurological symptoms were randomly assigned lamivudine plus either stavudine (n = 17) or zidovudine (n = 11). We did lumbar punctures on 28 individuals before and 22 individuals after 12 weeks of treatment to assess HIV-1-RNA and drug concentrations in cerebrospinal fluid.
Findings: All 28 individuals had detectable HIV-1-RNA concentrations in the cerebrospinal fluid (median 4.64 log10 copies/mL and 4.20 log10 copies/mL in the lamivudine plus zidovudine and lamivudine plus stavudine groups, respectively). There was no correlation between plasma and cerebrospinal-fluid HIV-1-RNA concentrations (r = 0.18, p = 0.35). After 12 weeks of treatment none of the individuals had detectable HIV-1-RNA concentrations in the cerebrospinal fluid. The highest drug concentration in the cerebrospinal fluid was for lamivudine followed by stavudine and zidovudine. Concentrations were consistent over time, unlike plasma concentrations. Therefore, we found time-dependent cerebrospinal-fluid to plasma drug-penetration ratios, which were highest for zidovudine followed by stavudine and lamivudine.
Interpretation: The two drug combinations were equally effective in the decrease of cerebrospinal fluid HIV-1-RNA concentrations. All drugs penetrated the cerebrospinal fluid. Antiretroviral drugs other than zidovudine might be useful in the prevention of AIDS dementia complex.
Comment in
-
Neurological efficacy of stavudine, zidovudine, and lamivudine.Lancet. 1998 Aug 1;352(9125):402. doi: 10.1016/S0140-6736(05)60498-9. Lancet. 1998. PMID: 9717950 No abstract available.
-
Neurological efficacy of stavudine, zidovudine, and lamivudine.Lancet. 1998 Aug 1;352(9125):402-3. doi: 10.1016/s0140-6736(05)60499-0. Lancet. 1998. PMID: 9717951 No abstract available.
Similar articles
-
Clinical implications of CNS penetration of antiretroviral drugs.CNS Drugs. 2002;16(9):595-609. doi: 10.2165/00023210-200216090-00002. CNS Drugs. 2002. PMID: 12153332 Review.
-
Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.AIDS. 2020 Nov 1;34(13):1883-1889. doi: 10.1097/QAD.0000000000002626. AIDS. 2020. PMID: 32694416
-
Neurological efficacy of stavudine, zidovudine, and lamivudine.Lancet. 1998 Aug 1;352(9125):402. doi: 10.1016/S0140-6736(05)60498-9. Lancet. 1998. PMID: 9717950 No abstract available.
-
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.Antivir Ther. 1999;4 Suppl 3:71-4. Antivir Ther. 1999. PMID: 16021874 Clinical Trial.
-
Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection.Drugs. 1996 May;51(5):846-64. doi: 10.2165/00003495-199651050-00009. Drugs. 1996. PMID: 8861550 Review.
Cited by
-
Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid.Antimicrob Agents Chemother. 2005 Jun;49(6):2504-6. doi: 10.1128/AAC.49.6.2504-2506.2005. Antimicrob Agents Chemother. 2005. PMID: 15917556 Free PMC article. Clinical Trial.
-
Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells.AIDS Res Hum Retroviruses. 2010 Jan;26(1):79-88. doi: 10.1089/aid.2009.0044. AIDS Res Hum Retroviruses. 2010. PMID: 20059395 Free PMC article.
-
Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.Retrovirology. 2017 Oct 16;14(1):47. doi: 10.1186/s12977-017-0370-5. Retrovirology. 2017. PMID: 29037245 Free PMC article.
-
Determination of nucleosidic/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry.Clin Mass Spectrom. 2018 Apr 25;8:8-20. doi: 10.1016/j.clinms.2018.04.001. eCollection 2018 Apr. Clin Mass Spectrom. 2018. PMID: 39192990 Free PMC article.
-
Clinical implications of CNS penetration of antiretroviral drugs.CNS Drugs. 2002;16(9):595-609. doi: 10.2165/00023210-200216090-00002. CNS Drugs. 2002. PMID: 12153332 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials